-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
39149104081
-
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
-
Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4):612-619.
-
(2008)
J Clin Oncol
, vol.26
, Issue.4
, pp. 612-619
-
-
Chaturvedi, A.K.1
Engels, E.A.2
Anderson, W.F.3
Gillison, M.L.4
-
3
-
-
84888305514
-
-
HPV associated oropharyngeal cancer rates by race and ethnicity [Internet]. Available from
-
HPV associated oropharyngeal cancer rates by race and ethnicity [Internet]. Available from: http://www.cdc.gov/cancer/hpv/statistics/headneck.htm.
-
-
-
-
4
-
-
33750616532
-
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer
-
Hammarstedt L., Lindquist D., Dahlstrand H., Romanitan M., Dahlgren L.O., Joneberg J., et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006, 119(11):2620-2623.
-
(2006)
Int J Cancer
, vol.119
, Issue.11
, pp. 2620-2623
-
-
Hammarstedt, L.1
Lindquist, D.2
Dahlstrand, H.3
Romanitan, M.4
Dahlgren, L.O.5
Joneberg, J.6
-
5
-
-
84863975396
-
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer
-
Gillison M.L., Zhang Q., Jordan R., Xiao W., Westra W.H., Trotti A., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012, 30(17):2102-2111.
-
(2012)
J Clin Oncol
, vol.30
, Issue.17
, pp. 2102-2111
-
-
Gillison, M.L.1
Zhang, Q.2
Jordan, R.3
Xiao, W.4
Westra, W.H.5
Trotti, A.6
-
6
-
-
0024514647
-
Allelotype of colorectal carcinomas
-
Vogelstein B., Fearon E.R., Kern S.E., Hamilton S.R., Preisinger A.C., Nakamura Y., et al. Allelotype of colorectal carcinomas. Science 1989, 244(4901):207-211.
-
(1989)
Science
, vol.244
, Issue.4901
, pp. 207-211
-
-
Vogelstein, B.1
Fearon, E.R.2
Kern, S.E.3
Hamilton, S.R.4
Preisinger, A.C.5
Nakamura, Y.6
-
7
-
-
0024535277
-
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
-
Hinds P., Finlay C., Levine A.J. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989, 63(2):739-746.
-
(1989)
J Virol
, vol.63
, Issue.2
, pp. 739-746
-
-
Hinds, P.1
Finlay, C.2
Levine, A.J.3
-
8
-
-
0031127553
-
Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles
-
Dupuy C., Buzoni-Gatel D., Touze A., Le Cann P., Bout D., Coursaget P. Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb Pathog 1997, 22(4):219-225.
-
(1997)
Microb Pathog
, vol.22
, Issue.4
, pp. 219-225
-
-
Dupuy, C.1
Buzoni-Gatel, D.2
Touze, A.3
Le Cann, P.4
Bout, D.5
Coursaget, P.6
-
9
-
-
0027358723
-
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
-
Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75(3):495-505.
-
(1993)
Cell
, vol.75
, Issue.3
, pp. 495-505
-
-
Scheffner, M.1
Huibregtse, J.M.2
Vierstra, R.D.3
Howley, P.M.4
-
10
-
-
0029029938
-
P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
-
Havre P.A., Yuan J., Hedrick L., Cho K.R., Glazer P.M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 1995, 55(19):4420-4424.
-
(1995)
Cancer Res
, vol.55
, Issue.19
, pp. 4420-4424
-
-
Havre, P.A.1
Yuan, J.2
Hedrick, L.3
Cho, K.R.4
Glazer, P.M.5
-
11
-
-
0033578418
-
Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
-
Oda H., Kumar S., Howley P.M. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci USA 1999, 96(17):9557-9562.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.17
, pp. 9557-9562
-
-
Oda, H.1
Kumar, S.2
Howley, P.M.3
-
12
-
-
0026705926
-
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells
-
Pagano M., Durst M., Joswig S., Draetta G., Jansen-Durr P. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene 1992, 7(9):1681-1686.
-
(1992)
Oncogene
, vol.7
, Issue.9
, pp. 1681-1686
-
-
Pagano, M.1
Durst, M.2
Joswig, S.3
Draetta, G.4
Jansen-Durr, P.5
-
13
-
-
0027515914
-
HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A
-
Tommasino M., Adamczewski J.P., Carlotti F., Barth C.F., Manetti R., Contorni M., et al. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 1993, 8(1):195-202.
-
(1993)
Oncogene
, vol.8
, Issue.1
, pp. 195-202
-
-
Tommasino, M.1
Adamczewski, J.P.2
Carlotti, F.3
Barth, C.F.4
Manetti, R.5
Contorni, M.6
-
14
-
-
0028325483
-
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
-
Demers G.W., Foster S.A., Halbert C.L., Galloway D.A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 1994, 91(10):4382-4386.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, Issue.10
, pp. 4382-4386
-
-
Demers, G.W.1
Foster, S.A.2
Halbert, C.L.3
Galloway, D.A.4
-
15
-
-
32944464047
-
Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma
-
Slebos R.J., Yi Y., Ely K., Carter J., Evjen A., Zhang X., et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12(3 Pt 1):701-709.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.3 PART 1
, pp. 701-709
-
-
Slebos, R.J.1
Yi, Y.2
Ely, K.3
Carter, J.4
Evjen, A.5
Zhang, X.6
-
16
-
-
42249105032
-
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
-
Martinez I., Gardiner A.S., Board K.F., Monzon F.A., Edwards R.P., Khan S.A. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008, 27(18):2575-2582.
-
(2008)
Oncogene
, vol.27
, Issue.18
, pp. 2575-2582
-
-
Martinez, I.1
Gardiner, A.S.2
Board, K.F.3
Monzon, F.A.4
Edwards, R.P.5
Khan, S.A.6
-
17
-
-
33751038688
-
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours
-
Ragin C.C., Taioli E., Weissfeld J.L., White J.S., Rossie K.M., Modugno F., et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006, 95(10):1432-1438.
-
(2006)
Br J Cancer
, vol.95
, Issue.10
, pp. 1432-1438
-
-
Ragin, C.C.1
Taioli, E.2
Weissfeld, J.L.3
White, J.S.4
Rossie, K.M.5
Modugno, F.6
-
18
-
-
34548680936
-
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis
-
Ragin C.C., Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121(8):1813-1820.
-
(2007)
Int J Cancer
, vol.121
, Issue.8
, pp. 1813-1820
-
-
Ragin, C.C.1
Taioli, E.2
-
19
-
-
77954190940
-
Human papillomavirus and survival of patients with oropharyngeal cancer
-
Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tan P.F., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363(1):24-35.
-
(2010)
N Engl J Med
, vol.363
, Issue.1
, pp. 24-35
-
-
Ang, K.K.1
Harris, J.2
Wheeler, R.3
Weber, R.4
Rosenthal, D.I.5
Nguyen-Tan, P.F.6
-
20
-
-
83955164347
-
A typical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy
-
Huang S.H., Perez-Ordonez B., Liu F.F., Waldron J., Ringash J., Irish J., et al. A typical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82(1):276-283.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
, Issue.1
, pp. 276-283
-
-
Huang, S.H.1
Perez-Ordonez, B.2
Liu, F.F.3
Waldron, J.4
Ringash, J.5
Irish, J.6
-
21
-
-
84888291008
-
-
NCCN clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013 [Internet], 2013:06/09.
-
NCCN clinical practice guidelines in oncology. Head and neck cancers. Version 2.2013 [Internet], 2013:06/09.
-
-
-
-
22
-
-
84864117653
-
Epidemiology and clinical aspects of HPV in head and neck cancers
-
Chaturvedi A.K. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol 2012, 6(Suppl 1):S16-S24.
-
(2012)
Head Neck Pathol
, vol.6
, Issue.SUPPL 1
-
-
Chaturvedi, A.K.1
-
23
-
-
77953450510
-
HPV & head and neck cancer: a descriptive update
-
Goon P.K., Stanley M.A., Ebmeyer J., Steinstrasser L., Upile T., Jerjes W., et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol 2009, 1(36). 10.1186/1758-3284-1-36.
-
(2009)
Head Neck Oncol
, vol.1
, Issue.36
-
-
Goon, P.K.1
Stanley, M.A.2
Ebmeyer, J.3
Steinstrasser, L.4
Upile, T.5
Jerjes, W.6
-
24
-
-
67650354892
-
Human papillomavirus-related head and neck tumors: clinical and research implication
-
Psyrri A., Gouveris P., Vermorken J.B. Human papillomavirus-related head and neck tumors: clinical and research implication. Curr Opin Oncol 2009, 21(3):201-205.
-
(2009)
Curr Opin Oncol
, vol.21
, Issue.3
, pp. 201-205
-
-
Psyrri, A.1
Gouveris, P.2
Vermorken, J.B.3
-
25
-
-
84863196741
-
Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment
-
Attner P., Nasman A., Du J., Hammarstedt L., Ramqvist T., Lindholm J., et al. Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment. Int J Cancer 2012, 131(5):1124-1130.
-
(2012)
Int J Cancer
, vol.131
, Issue.5
, pp. 1124-1130
-
-
Attner, P.1
Nasman, A.2
Du, J.3
Hammarstedt, L.4
Ramqvist, T.5
Lindholm, J.6
-
26
-
-
79953124785
-
The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview
-
Pannone G., Santoro A., Papagerakis S., Lo Muzio L., De Rosa G., Bufo P. The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer 2011, 6(4). 10.1186/1750-9378-6-4.
-
(2011)
Infect Agent Cancer
, vol.6
, Issue.4
-
-
Pannone, G.1
Santoro, A.2
Papagerakis, S.3
Lo Muzio, L.4
De Rosa, G.5
Bufo, P.6
-
27
-
-
65349173893
-
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
-
Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009, 27(12):1992-1998.
-
(2009)
J Clin Oncol
, vol.27
, Issue.12
, pp. 1992-1998
-
-
Lassen, P.1
Eriksen, J.G.2
Hamilton-Dutoit, S.3
Tramm, T.4
Alsner, J.5
Overgaard, J.6
-
28
-
-
79960367969
-
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial
-
Lassen P., Eriksen J.G., Krogdahl A., Therkildsen M.H., Ulhoi B.P., Overgaard M., et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial. Radiother Oncol 2011, 100(1):49-55.
-
(2011)
Radiother Oncol
, vol.100
, Issue.1
, pp. 49-55
-
-
Lassen, P.1
Eriksen, J.G.2
Krogdahl, A.3
Therkildsen, M.H.4
Ulhoi, B.P.5
Overgaard, M.6
-
29
-
-
39649109915
-
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
-
Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-269.
-
(2008)
J Natl Cancer Inst
, vol.100
, Issue.4
, pp. 261-269
-
-
Fakhry, C.1
Westra, W.H.2
Li, S.3
Cmelak, A.4
Ridge, J.A.5
Pinto, H.6
-
30
-
-
79955514313
-
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
-
Posner M.R., Lorch J.H., Goloubeva O., Tan M., Schumaker L.M., Sarlis N.J., et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 2011, 22(5):1071-1077.
-
(2011)
Ann Oncol
, vol.22
, Issue.5
, pp. 1071-1077
-
-
Posner, M.R.1
Lorch, J.H.2
Goloubeva, O.3
Tan, M.4
Schumaker, L.M.5
Sarlis, N.J.6
-
31
-
-
77957955293
-
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial
-
Rischin D., Young R.J., Fisher R., Fox S.B., Le Q.T., Peters L.J., et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010, 28(27):4142-4148.
-
(2010)
J Clin Oncol
, vol.28
, Issue.27
, pp. 4142-4148
-
-
Rischin, D.1
Young, R.J.2
Fisher, R.3
Fox, S.B.4
Le, Q.T.5
Peters, L.J.6
-
32
-
-
84884135749
-
ECOG 1308: a phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). 2012 ASCO annual meeting
-
Marur S, Lee J, Cmelak A, Zhao W, Westra W, Chung C, et al. ECOG 1308: a phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). 2012 ASCO annual meeting. J Clin Oncol 2012.
-
(2012)
J Clin Oncol
-
-
Marur, S.1
Lee, J.2
Cmelak, A.3
Zhao, W.4
Westra, W.5
Chung, C.6
-
33
-
-
84869507343
-
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee clinical trials planning meeting, November 6-7, 2011, Arlington, Virginia
-
Adelstein D.J., Ridge J.A., Brizel D.M., Holsinger F.C., Haughey B.H., O'Sullivan B., et al. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee clinical trials planning meeting, November 6-7, 2011, Arlington, Virginia. Head Neck 2012, 34(12):1681-1703.
-
(2012)
Head Neck
, vol.34
, Issue.12
, pp. 1681-1703
-
-
Adelstein, D.J.1
Ridge, J.A.2
Brizel, D.M.3
Holsinger, F.C.4
Haughey, B.H.5
O'Sullivan, B.6
-
34
-
-
84888301476
-
-
RTOG 1016 protocol information: Phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer [Internet]; 2013. Available from:
-
RTOG 1016 protocol information: Phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer [Internet]; 2013. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1016.
-
-
-
-
35
-
-
84888293599
-
-
Phase II randomized trial of transoral surgical resection followed by low- dose or standard dose IMRT in resectable p16+ locally advanced oropharynx cancer [Internet]; Aug 2013. Available from:
-
Phase II randomized trial of transoral surgical resection followed by low- dose or standard dose IMRT in resectable p16+ locally advanced oropharynx cancer [Internet]; Aug 2013. Available from: http://ecog-acrin.org/trials/head-and-neck.
-
-
-
-
36
-
-
79958272187
-
Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study
-
Haughey B.H., Hinni M.L., Salassa J.R., Hayden R.E., Grant D.G., Rich J.T., et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011, 33(12):1683-1694.
-
(2011)
Head Neck
, vol.33
, Issue.12
, pp. 1683-1694
-
-
Haughey, B.H.1
Hinni, M.L.2
Salassa, J.R.3
Hayden, R.E.4
Grant, D.G.5
Rich, J.T.6
-
37
-
-
84875318185
-
Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma
-
Olsen S.M., Moore E.J., Laborde R.R., Garcia J.J., Janus J.R., Price D.L., et al. Transoral surgery alone for human-papillomavirus-associated oropharyngeal squamous cell carcinoma. Ear Nose Throat J 2013, 92(2):76-83.
-
(2013)
Ear Nose Throat J
, vol.92
, Issue.2
, pp. 76-83
-
-
Olsen, S.M.1
Moore, E.J.2
Laborde, R.R.3
Garcia, J.J.4
Janus, J.R.5
Price, D.L.6
-
38
-
-
84864067591
-
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control
-
Weinstein G.S., Quon H., Newman H.J., Chalian J.A., Malloy K., Lin A., et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg 2012, 138(7):628-634.
-
(2012)
Arch Otolaryngol Head Neck Surg
, vol.138
, Issue.7
, pp. 628-634
-
-
Weinstein, G.S.1
Quon, H.2
Newman, H.J.3
Chalian, J.A.4
Malloy, K.5
Lin, A.6
-
39
-
-
84874407327
-
Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes
-
Quon H., Cohen M.A., Montone K.T., Ziober A.F., Wang L.P., Weinstein G.S., et al. Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 2013, 123(3):635-640.
-
(2013)
Laryngoscope
, vol.123
, Issue.3
, pp. 635-640
-
-
Quon, H.1
Cohen, M.A.2
Montone, K.T.3
Ziober, A.F.4
Wang, L.P.5
Weinstein, G.S.6
-
40
-
-
84855646939
-
Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function
-
Leonhardt F.D., Quon H., Abrahao M., O'Malley B.W., Weinstein G.S. Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 2012, 34(2):146-154.
-
(2012)
Head Neck
, vol.34
, Issue.2
, pp. 146-154
-
-
Leonhardt, F.D.1
Quon, H.2
Abrahao, M.3
O'Malley, B.W.4
Weinstein, G.S.5
-
41
-
-
77956573724
-
Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial
-
Weinstein G.S., Quon H., O'Malley B.W., Kim G.G., Cohen M.A. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial. Laryngoscope 2010, 120(9):1749-1755.
-
(2010)
Laryngoscope
, vol.120
, Issue.9
, pp. 1749-1755
-
-
Weinstein, G.S.1
Quon, H.2
O'Malley, B.W.3
Kim, G.G.4
Cohen, M.A.5
-
42
-
-
84875061795
-
Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR) - study protocol for a randomized phase II trial
-
Nichols A.C., Yoo J., Hammond J.A., Fung K., Winquist E., Read N., et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR) - study protocol for a randomized phase II trial. BMC Cancer 2013, 13(133). 10.1186/1471-2407-13-133.
-
(2013)
BMC Cancer
, vol.13
, Issue.133
-
-
Nichols, A.C.1
Yoo, J.2
Hammond, J.A.3
Fung, K.4
Winquist, E.5
Read, N.6
-
43
-
-
84875421186
-
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis
-
O'Sullivan B., Huang S.H., Siu L.L., Waldron J., Zhao H., Perez-Ordonez B., et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013, 31(5):543-550.
-
(2013)
J Clin Oncol
, vol.31
, Issue.5
, pp. 543-550
-
-
O'Sullivan, B.1
Huang, S.H.2
Siu, L.L.3
Waldron, J.4
Zhao, H.5
Perez-Ordonez, B.6
-
44
-
-
84863307023
-
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma
-
Sinha P., Lewis J.S., Piccirillo J.F., Kallogjeri D., Haughey B.H. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 2012, 118(14):3519-3530.
-
(2012)
Cancer
, vol.118
, Issue.14
, pp. 3519-3530
-
-
Sinha, P.1
Lewis, J.S.2
Piccirillo, J.F.3
Kallogjeri, D.4
Haughey, B.H.5
-
45
-
-
84876412614
-
Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors
-
Klozar J., Koslabova E., Kratochvil V., Salakova M., Tachezy R. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol 2013, 107(6):625-633.
-
(2013)
J Surg Oncol
, vol.107
, Issue.6
, pp. 625-633
-
-
Klozar, J.1
Koslabova, E.2
Kratochvil, V.3
Salakova, M.4
Tachezy, R.5
-
46
-
-
84888287786
-
-
Phase II trial evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer [Internet]. Available from:
-
Phase II trial evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer [Internet]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01469546?term=axitinib&rank=14.
-
-
-
-
47
-
-
49249095295
-
EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
-
Kumar B., Cordell K.G., Lee J.S., Worden F.P., Prince M.E., Tran H.H., et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008, 26(19):3128-3137.
-
(2008)
J Clin Oncol
, vol.26
, Issue.19
, pp. 3128-3137
-
-
Kumar, B.1
Cordell, K.G.2
Lee, J.S.3
Worden, F.P.4
Prince, M.E.5
Tran, H.H.6
-
48
-
-
84871918505
-
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies
-
Ramos C.A., Narala N., Vyas G.M., Leen A.M., Gerdemann U., Sturgis E.M., et al. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies. J Immunother 2013, 36(1):66-76.
-
(2013)
J Immunother
, vol.36
, Issue.1
, pp. 66-76
-
-
Ramos, C.A.1
Narala, N.2
Vyas, G.M.3
Leen, A.M.4
Gerdemann, U.5
Sturgis, E.M.6
|